Sexual and sporogonic stage antigens

Chemical Immunology

Volumn 80, Issue , 2002, Pages 188-203

  Sauerwein, R W ^a   Eling, W M C ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN PFG27; ANTIGEN PFS16; ANTIGEN PFS230; ANTIGEN PFS25; ANTIGEN PFS28; ANTIGEN PFS45; ANTIGEN PFS48; CHITINASE; PARASITE ANTIGEN; PROTOZOAL PROTEIN; TRAP RELATED PROTEIN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; CELL INVASION; ERYTHROCYTE MEMBRANE; GAMETOCYTE; PARASITE DEVELOPMENT; PARASITE TRANSMISSION; PLASMODIUM; PRIORITY JOURNAL; PROTEIN FAMILY; REPRODUCTION; REVIEW; SPOROGENESIS;

EID: 0036090251     PISSN: 10150145     EISSN: None     Source Type: Journal    
DOI: 10.1159/000058855     Document Type: Review

References (92)

1. Gametocytes
2. Malaria transmission-blocking vaccine-how can their development be supported?
3. Malaria eradication on islands
4. Transmission-blocking vaccines
5. Antimalarial transmission-blocking vaccines
6. Sexual differentiation and development in the malaria parasite
7. Commitment to gametocytogenesis
8. Synchronization of P. falciparum gametocytes using an automated suspension culture system
9. Sexual differentiation in malaria parasites
10. The biology of P. falciparum transmission stages
11. Plasmodium sexual stage antigens
12. The distribution of P. falciparum in the peripheral blood and bone marrow of Gambian children
13. Molecular aspects of severe malaria
14. Virulence and transmission success of the malaria parasite P. falciparum
15. A model for sequestration of the transmission stages of P. falciparum: Adhesion of gametocyte-infected erythrocytes to human bone marrow cells
16. Malaria transmission and naturally acquired immunity to PfEMP-1
17. Commitment of the malaria parasite P. falciparum to sexual and asexual development
18. Expression of early gametocyte-stage antigens Pfg 27 and Pfs 16 in synchronised gametocytes producing clones of P. falciparum
19. Developmentally regulated espressin of Pfs16, a marker for sexual stage differentiation of the human malaria parasite P. falciparum
20. Subcellular localization of Pfs16, a Plasmodium falciparum gametocyte antigen
21. Cellular location and temporal expression of the P. falciparum sexual stage antigen Pfs16
22. Humoral immune responses in Gambians to Pfs16, an immunodominant, P. falciparum integral membrane protein
23. Antibody responses to P. falciparum gametocyte antigens during and after the malaria attacks in school children from Madang, Papua New Guinea
24. P. falciparum: An abundant stage-specific protein expressed during early gametocyte development
25. Disruption of the Pfg27 locus by homologous recombination leads to loss of the sexual stage phenotype in P. falciparum
26. Identification of a continuous and cross-reacting epitope for Plasmodium falciparum transmission-blocking immunity
27. Mapping of specific and promiscuous HLA-DR-restricted T-cell epitopes on the Plasmodium falciparum 27-kilodalton sexual stage-specific antigen
28. Identification of additional members define a Plasmodium falciparum gene superfamily which includes Pfs48/45 and Pfs230
29. Predicted disulphide-bonded structures for three uniquely related proteins of Plasmodium falciparum, Pfs230, Pfs48/45 and Pf112
30. Cloning and expression of the gene for Plasmodium falciparum transmission-blocking target antigen, Pfs230
31. A central role for P48/45 in malaria parasite male gamete fertility
32. Characterization of Plasmodium falciparum sexual stage antigens and their biosynthesis in synchronised gametocyte cultures
33. Proteolysis of Plasmodium falciparum surface antigen, Pfs230, during gametogenesis
34. Phase separation in Triton X-114 of antigens of transmission blocking immunity in Plasmodium gallinaceum
35. Target antigens of malaria transmission-blocking immunity exist as a stable membrane bound complex
36. Sequential expression of antigens on sexual stages of Plasmodium falciparum accessible to transmission blocking antibodies in the mosquito
37. Cloning and expression of the gene coding for the transmission-blocking antigen Pfs48/45 of Plasmodium falciparum
38. Plasmodium falciparum: Expression of gametocyte-specific genes in cultures and malaria-positive blood samples
39. Characterisation of antigens on mosquito midgut stages of Plasmodium gallinaceum. II. Comparison of surface antigens of male and female gametes and zygotes
40. Immunological properties of recombinant proteins of the transmission-blocking vaccine candidate Pfs48/45, of the human malaria parasite Plasmodium falciparum produced in E. coli
41. Conserved and variant epitopes of target antigens of transmission-blocking antibodies among isolates of P. falciparum from Malaysia
42. Minimal variation in the transmission-blocking vaccine candidate Pfs48/45 of the human malaria parasite Plasmodium falciparum
43. Geographical distribution of a variant epitope of Pfs48/45, a Plasmodium falciparum transmission-blocking vaccine candidate
44. Properties of epitopes of Pfs48/45, a target of transmission-blocking monoclonal antibodies, on gametes of different isolates
45. Plasmodium falciparum sexual stage antigens: Immunogenecity and cell mediated responses
46. Association between anti-Pfs48/45 reactivity and P. falciparum transmission-blocking activity in sera from Cameroon
47. Plasmodium falciparum: Natural and experimental transmission blocking immunity
48. Plasmodium falciparum: Production and characterisation of rat monoclonal antibodies specific for the sexual stage Pfs48/45 antigen
49. Target antigens of transmission-blocking immunity on gametes of Plasmodium falciparum
50. Two apparently non-repeated epitopes on gametes of P. falciparum are targets of transmission blocking antibodies
51. Differential non-responsiveness in humans of candidate Plasmodium falciparum vaccine antigens
52. Antibodies to P. falciparum gamete surface antigens in Papua New Guinea sera
53. Association between HLA type and antibody response to malaria sporozoite and gametocyte epitopes is not evident in immune Papua New Guineans
54. A comparison of transmission blocking activity with reactivity in a Plasmodium falciparum 48/45-kD molecule-specific competition enzyme-linked immunoassay
55. Human antibody responses to epitopes on the Plasmodium falciparum antigen Pfs48/45 and their relationship to infectivity of gametocyte carriers
56. Plasmodium falciparum: Membrane feeding assays and competition ELISAs for the measurement of transmission reduction in sera from Cameroon
57. Transmission-blocking effects of sera from malaria-exposed individuals on Plasmodium falciparum isolates from gametocyte carriers
58. Plasmodium falciparum: A comparison of the activity of Pfs230-specific antibodies in an assay of transmission-blocking immunity and specific competition ELISAs
59. Recombinant Pfs230, a Plasmodium falciparum gametocyte protein, induces antisera that reduce the infectivity of Plasmodium falciparum to mosquitoes
60. The 230 kDa gamete surface protein of Plasmodium falciparum is also target for transmission-blocking antibodies
61. Transmission blockade of Plasmodium falciparum by anti-Pfs230 specific antibodies is isotype specific
62. Monoclonal antibodies against surface determinants of gametes of P. gallinaceum block transmission of malaria parasites to mosquitoes
63. Plasmodium falciparum malaria transmission blocking immunity under conditions of low endemicity as in Sri Lanka
64. Complement-mediated lysis of Plasmodium falciparum gametes by malaria-immune human sera is associated with antibodies to the gamete surface antigen Pfs230
65. A vaccine candidate from the sexual stages of human malaria that contains EGF-like domains
66. Differential ability of specific regions of Plasmodium falciparum sexual stage antigen Pfs230, to induce malaria transmission-blocking
67. Transmission-blocking immunity to Plasmodium falciparum in malaria-immune individuals is associated with antibodies to the gamete surface protein Pfs230
68. Pgs28 belongs to a family of epidermal growth factor-like antigens that are targets of malaria transmission-blocking antibodies
69. Biosynthesis of two stage-specific membrane proteins during transformation of P. gallinaceum zygotes into ookinetes
70. A novel malaria protein, Pfs28, and pfs25 are genetically linked and synergistic as falciparum malaria transmission-blocking vaccines
71. Saccharomyces cerevisiae recombinant Pfs25-adsorbed to alum elicits antibodies that block transmission of P. falciparum
72. A region of P. falciparum antigen Pfs25 that is target of highly potent transmission-blocking antibodies
73. Anti-Pfs25 monoclonal antibody 32F81 blocks transmission from P. falciparum gametocyte carriers in Cameroon
74. The peritrophic membrane as a barrier: Its penetration by P. gallinaceum and the effect of a monoclonal antibody to ookinetes
75. Ookinete antigens of P. berghei appearance on the zygote of an M 21 kDa surface determinant identified by transmission blocking monoclonal antibodies
76. Primary structure of a novel ookinete surface protein from P. berghei
77. Characterisation and expression of Pbs25, a sexual and sporogonic stage specific protein of P. berghei
78. P25 and P28 proteins of the malaria ookinete surface have multiple and partially redundant functions
79. Saccharomyces cerevisiae-secreted fusion proteins Pfs25 and Pfs28 elicit potent P. falciparum transmisson-blocking antibodies in mice
80. Minimal variation in a vaccine candidate from the sexual stage of P. falciparum
81. Minimal variation in the ookinete antigen from Philippine field isolates of P. falciparum
82. Sequence and polymorphism in two P vivax ookinete surface proteins, Pvs25 and Pvs28, that are malaria transmission-blocking vaccine candidates
83. Antibodies to malaria vaccine candidates Pvs25 and Pvs28 completely block the ability of P. vivax to infect mosquitoes
84. The thrombospondin-related protein family of apicomplexan parasites: The gears of the cell invasion machinery
85. Structure and expression of an adhesive protein-like molecule of mosquito invasive-stage malarial parasite
86. CTRP is essential for mosquito infection by malaria ookinetes
87. Molecular cloning of a gene of P. falciparum that codes for a protein sharing motifs found in adhesive molecules from mammals and plasmodia
88. Developmental arrest of the human malaria parasite P. falciparum within the mosquito midgut via CTRP gene disruption
89. Chitinase: A novel target for blocking parasite transmission
90. Transmission-blocking activity of a chitinase inhibitor and activation of malaria parasite chitinase by mosquito protease
91. Chitinase of the avian malaria parasite P. gallinaceum, a class of enzymes necessary for parasite invasion of the mosquito midgut